| Entry |
|
|---|
| Name |
Mycophenolate sodium (USP);
Myfortic (TN) |
|---|
| Product |
|
|---|
| Generic |
MYCOPHENOLIC ACID (A-S Medication Solutions), MYCOPHENOLIC ACID (Accord Healthcare), MYCOPHENOLIC ACID (Advagen Pharma Limited), MYCOPHENOLIC ACID (American Health Packaging), MYCOPHENOLIC ACID (Apotex Corp), MYCOPHENOLIC ACID (Archis Pharma LLC), MYCOPHENOLIC ACID (Ascend Laboratories), MYCOPHENOLIC ACID (Aurobindo Pharma Limited), MYCOPHENOLIC ACID (Biocon Pharma), MYCOPHENOLIC ACID (CONCORD BIOTECH LIMITED), MYCOPHENOLIC ACID (Golden State Medical Supply), MYCOPHENOLIC ACID (Major Pharmaceuticals), MYCOPHENOLIC ACID (Major Pharmaceuticals), MYCOPHENOLIC ACID (PD-Rx Pharmaceuticals), MYCOPHENOLIC ACID (REMEDYREPACK), MYCOPHENOLIC ACID (Slate Run Pharmaceuticals), MYCOPHENOLIC ACID (TWi Pharmaceuticals), MYCOPHENOLIC ACID (airis PHARMA Private Limited) |
|---|
| Formula |
C17H19O6. Na
|
|---|
| Exact mass |
342.1079
|
|---|
| Mol weight |
342.3189
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG00739): | D00752<JP/US> D05094<US> D05095<US> |
|
|---|
| Efficacy |
Immunosuppressant, Inosine monophosphate dehydrogenase inhibitor |
|---|
| Disease |
Organ rejection in kidney transplant [DS: H00083] |
|---|
| Comment |
Prophylaxis of organ rejection in kidney transplant
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AA Selective immunosuppressants
L04AA06 Mycophenolic acid
D05095 Mycophenolate sodium (USP) <US>
USP drug classification [BR:br08302]
Immunological Agents
Immunosuppressants
Antimetabolites, Antiproliferative
Mycophenolic Acid
D05095 Mycophenolate sodium (USP)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
IMPDH
D05095 Mycophenolate sodium (USP) <US>
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D05095
Prodrugs [br08324.html]
DG00739
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C8y C 32.5108 -17.7327
2 C8y C 32.5050 -16.3189
3 C8y C 31.2957 -18.4278
4 C1x C 33.8487 -18.1650
5 C8y C 31.2957 -15.6179
6 C7x C 33.8427 -15.8865
7 C8y C 30.0805 -17.7327
8 C1a C 31.2957 -19.8358
9 O7x O 34.6723 -17.0258
10 C8y C 30.0805 -16.3189
11 O1a O 31.2957 -14.2158
12 O6a O 34.2810 -14.5488
13 O2a O 28.8654 -18.4278
14 C1b C 28.8654 -15.6179
15 C1a C 28.8654 -19.8358
16 C2b C 27.6504 -16.3132
17 C2c C 26.4352 -15.6121
18 C1b C 25.2258 -16.3072
19 C1a C 26.4411 -14.2100
20 C1b C 24.0108 -15.6062
21 C6a C 22.7957 -16.2955
22 O6a O 21.5805 -15.6005 #-
23 O6a O 22.7899 -17.7034
24 Z Na 18.8300 -15.5400 #+
BOND 24
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 3 8 1
8 4 9 1
9 5 10 2
10 5 11 1
11 6 12 2
12 7 13 1
13 10 14 1
14 13 15 1
15 14 16 1
16 16 17 2
17 17 18 1
18 17 19 1
19 18 20 1
20 20 21 1
21 21 22 1
22 21 23 2
23 6 9 1
24 7 10 1
|
|---|
